Maplelane Capital’s Teladoc Health TDOC Stock Holding History

Maplelane Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1	Closed	–	–	154
2019 Q4	$0	Hold	1	–	–	﹤0.01%	186
2019 Q3	$0	Buy	+1	New	+$66	﹤0.01%	174

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Maplelane Capital's TDOC Position: Q1 2020 in Review

Maplelane Capital sold out of Teladoc Health (TDOC) in Q1 2020, closing a stake of 1 share.

Maplelane Capital first reported a position in TDOC in Q3 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2019. 578 funds tracked by Wall St. Rank hold TDOC as of Q1 2020.

Maplelane Capital reported no remaining Teladoc Health position as of Q1 2020 after selling out during the quarter.
Maplelane Capital sold 1 Teladoc Health share in Q1 2020.
Maplelane Capital first reported a position in Teladoc Health in Q3 2019 and held it in 2 quarters.
Maplelane Capital's Teladoc Health position peaked at $0 in Q4 2019.
578 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2020.

Based on Maplelane Capital's 13F filing for Q1 2020, filed 15 May 2020.